Cardiac Remodeling: Clinical Trials

2 trials for Cardiac Remodeling, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Cardiac Remodeling: new trials by email Literature Review of Cardiac Remodeling trials Research Report on Cardiac Remodeling

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction
Paroxetine, Placebo oral capsule - Cardiac Remodeling, Myocardial Infarction
Phase 2CompletedInsel Gruppe AG, University Hospital Bern502017-10-262022-06-01
Post-Myocardial Infarction Remodeling Prevention Therapy
Single Site Pacing, Dual Site Pacing - Acute Myocardial Infarction, Pacing Therapy
Phase 2CompletedMedtronic Cardiac Rhythm and Heart Failure1292010-12-012016-12-15

Narrower conditions

Heart Failure (1)  ·  Myocardial Infarction (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Infarction (1)  ·  Ischemia (1)  ·  Myocardial Ischemia (1)  ·  Necrosis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Paroxetine (1)

Sponsors

Insel Gruppe AG, University Hospital Bern (1)  ·  Medtronic Cardiac Rhythm and Heart Failure (1)

Countries

Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Saudi Arabia (1)  ·  Slovakia (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Angel Leon, MD (1)  ·  Gregg Stone, MD (1)  ·  Thomas Pilgrim, MD (1)

Results publications

PMID 26321236, PMID 34259826, PMID 36000427

NIH funding

2016 (1)